NCT00006480View on ClinicalTrials.gov

Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2000

Study Completion Date

March 31, 2005

Conditions
Neuroblastoma
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

therapeutic autologous lymphocytes

DRUG

chemotherapy

DRUG

ganciclovir

Trial Locations (2)

91010-3000

Cancer Center and Beckman Research Institute, City of Hope, Duarte

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00006480 - Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma | Biotech Hunter | Biotech Hunter